| Product | Indications | Discovery | Preclinical | Phase 1 | Phase 2 | Phase 3 | Status |
|---|---|---|---|---|---|---|---|
MNPR‑101‑Zr (Oncology) |
Advanced Solid Cancers (Imaging) |
Discovery complete |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Phase 1 Clinical Trial Active and Recruiting |
MNPR-101-Lu (Oncology) |
Advanced Solid Cancers |
Discovery complete |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Phase 1a Clinical Trial Active and Recruiting |
MNPR-101-Ac (Oncology) |
Advanced Solid Cancers |
Discovery complete |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Late Preclinical |
Early Pipeline (Oncology) |
Solid cancers |
Discovery complete |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Early Preclinical |
Early Pipeline (Oncology) |
Solid cancers |
Discovery in progress |
Preclinical not started |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Discovery |
ALXN1840 (Rare Disease) |
Wilson Disease |
Discovery complete |
Preclinical complete |
Phase 1 complete |
Phase 2 complete |
Phase 3 in progress |
Phase 3 - Primary Endpoint Met Phase 2 - MOA Inconclusive, Endpoints Not Met |
